{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:21:03Z","timestamp":1792102863936,"version":"4.4.0"},"reference-count":290,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010950","name":"Department of Science and Technology of Henan Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013072","name":"Major Science and Technology Project of Hainan Province","doi-asserted-by":"publisher","award":["221100310200"],"award-info":[{"award-number":["221100310200"]}],"id":[{"id":"10.13039\/501100013072","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Materials Today Bio"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.mtbio.2025.102537","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T05:44:21Z","timestamp":1763444661000},"page":"102537","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["From design to Deployment: The innovative role of nanomicelles in targeted ophthalmic therapeutics"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-1284-3748","authenticated-orcid":false,"given":"Mengli","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiale","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kexin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiehao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenao","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengzhi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihui","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Ge","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongming","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mtbio.2025.102537_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2020.100898","article-title":"Overcoming negatively charged tissue barriers: drug delivery using cationic peptides and proteins","volume":"34","author":"Vedadghavami","year":"2020","journal-title":"Nano Today"},{"issue":"6","key":"10.1016\/j.mtbio.2025.102537_bib2","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.drudis.2021.02.027","article-title":"Advanced nanodelivery platforms for topical ophthalmic drug delivery","volume":"26","author":"Gholizadeh","year":"2021","journal-title":"Drug Discov. Today"},{"issue":"11","key":"10.1016\/j.mtbio.2025.102537_bib3","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.addr.2006.07.027","article-title":"Challenges and obstacles of ocular pharmacokinetics and drug delivery","volume":"58","author":"Urtti","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"10.1016\/j.mtbio.2025.102537_bib4","doi-asserted-by":"crossref","DOI":"10.1208\/s12248-008-9024-9","article-title":"Topical ocular delivery of NSAIDs","volume":"10","author":"Ahuja","year":"2008","journal-title":"AAPS J."},{"issue":"20","key":"10.1016\/j.mtbio.2025.102537_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242015352","article-title":"Overview of recent advances in nano-based ocular drug delivery","volume":"24","author":"Liu","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.mtbio.2025.102537_bib6","doi-asserted-by":"crossref","first-page":"8279","DOI":"10.1166\/jnn.2014.9912","article-title":"Preparation of Poly(BMA-co-MMA) particles by soap-free emulsion polymerization and its optical properties as photonic crystals","volume":"14","author":"Lee","year":"2014","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/j.mtbio.2025.102537_bib7","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jconrel.2014.05.031","article-title":"Nanotherapy for posterior eye diseases","volume":"193","author":"Kaur","year":"2014","journal-title":"J Control Release"},{"issue":"3\u20134","key":"10.1016\/j.mtbio.2025.102537_bib8","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.drudis.2007.10.021","article-title":"Nanotechnology in ocular drug delivery","volume":"13","author":"Sahoo","year":"2008","journal-title":"Drug Discov. Today"},{"issue":"1","key":"10.1016\/j.mtbio.2025.102537_bib9","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ijpharm.2012.08.042","article-title":"Polymeric micelles and alternative nanonized delivery vehicles for poorly soluble drugs","volume":"453","author":"Lu","year":"2013","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.mtbio.2025.102537_bib10","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s11095-006-9223-y","article-title":"Functionalized micellar systems for cancer targeted drug delivery","volume":"24","author":"Sutton","year":"2007","journal-title":"Pharm. Res."},{"issue":"9","key":"10.1016\/j.mtbio.2025.102537_bib11","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1016\/j.biomaterials.2010.11.082","article-title":"Oral pharmacokinetics of the anti-HIV efavirenz encapsulated within polymeric micelles","volume":"32","author":"Chiappetta","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.mtbio.2025.102537_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2023.1246974","article-title":"Recent development of polymer nanomicelles in the treatment of eye diseases","volume":"11","author":"Cai","year":"2023","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"3","key":"10.1016\/j.mtbio.2025.102537_bib13","doi-asserted-by":"crossref","DOI":"10.1167\/tvst.4.3.1","article-title":"Topical, aqueous, clear cyclosporine formulation design for anterior and posterior ocular delivery","volume":"4","author":"Cholkar","year":"2015","journal-title":"Transl. Vis. Sci. Technol."},{"issue":"4","key":"10.1016\/j.mtbio.2025.102537_bib14","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1089\/jop.2014.0152","article-title":"Development and evaluation of dexamethasone nanomicelles with potential for treating posterior uveitis after topical application","volume":"31","author":"Patel","year":"2015","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"issue":"11","key":"10.1016\/j.mtbio.2025.102537_bib15","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.addr.2006.07.024","article-title":"Drug transport in corneal epithelium and blood\u2013retina barrier: emerging role of transporters in ocular pharmacokinetics","volume":"58","author":"Mannermaa","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.mtbio.2025.102537_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics10010028","article-title":"Ocular drug delivery barriers\u2014role of nanocarriers in the treatment of anterior segment ocular diseases","volume":"10","author":"Bachu","year":"2018","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.mtbio.2025.102537_bib17","first-page":"264","article-title":"Determination of tear volume and tear flow","volume":"5","author":"Mishima","year":"1966","journal-title":"Investig. Ophthalmol."},{"issue":"3","key":"10.1016\/j.mtbio.2025.102537_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12030253","article-title":"Assembling surfactants-mucoadhesive polymer nanomicelles (ASMP-Nano) for ocular delivery of Cyclosporine-A","volume":"12","author":"Terreni","year":"2020","journal-title":"Pharmaceutics"},{"issue":"43","key":"10.1016\/j.mtbio.2025.102537_bib19","doi-asserted-by":"crossref","first-page":"39603","DOI":"10.1021\/acsami.9b13851","article-title":"Overcoming the anatomical and physiological barriers in topical eye surface medication using a peptide-decorated polymeric micelle","volume":"11","author":"Lin","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"2","key":"10.1016\/j.mtbio.2025.102537_bib20","doi-asserted-by":"crossref","DOI":"10.4103\/ijo.IJO_646_17","article-title":"Anatomy of cornea and ocular surface","volume":"66","author":"Sridhar","year":"2018","journal-title":"Indian J. Ophthalmol."},{"issue":"4","key":"10.1016\/j.mtbio.2025.102537_bib21","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3109\/02713688509025145","article-title":"Transport processes across the rabbit corneal epithelium: a review","volume":"4","author":"Klyce","year":"1985","journal-title":"Curr. Eye Res."},{"issue":"9","key":"10.1016\/j.mtbio.2025.102537_bib22","doi-asserted-by":"crossref","first-page":"951","DOI":"10.3109\/02713689509000002","article-title":"Freeze-fracture quantitative comparison of rabbit corneal epithelial and endothelial membranes","volume":"4","author":"McLaughlin","year":"1985","journal-title":"Curr. Eye Res."},{"issue":"1","key":"10.1016\/j.mtbio.2025.102537_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/02713680802518251","article-title":"Molecular expression and functional evidence of a drug efflux pump (BCRP) in human corneal epithelial cells","volume":"34","author":"Karla","year":"2009","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.mtbio.2025.102537_bib24","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.jconrel.2022.07.019","article-title":"Cyclosporine-loaded micelles for ocular delivery: investigating the penetration mechanisms","volume":"349","author":"Ghezzi","year":"2022","journal-title":"J Control Release"},{"issue":"6","key":"10.1016\/j.mtbio.2025.102537_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14061277","article-title":"Design of an L-Valine-Modified nanomicelle-based drug delivery system for overcoming ocular surface barriers","volume":"14","author":"Wu","year":"2022","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.mtbio.2025.102537_bib26","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ejpb.2004.12.007","article-title":"Roles of the conjunctiva in ocular drug delivery: a review of conjunctival transport mechanisms and their regulation","volume":"60","author":"Hosoya","year":"2005","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"12","key":"10.1016\/j.mtbio.2025.102537_bib27","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.3109\/02713689608995151","article-title":"A primary culture model of rabbit conjunctival epithelial cells exhibiting tight barrier properties","volume":"15","author":"Saha","year":"1996","journal-title":"Curr. Eye Res."},{"issue":"2","key":"10.1016\/j.mtbio.2025.102537_bib28","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1021\/acs.molpharmaceut.0c00224","article-title":"Nanoparticulate drug delivery to the retina","volume":"18","author":"Li","year":"2021","journal-title":"Mol. Pharm."},{"issue":"7","key":"10.1016\/j.mtbio.2025.102537_bib29","first-page":"1221","article-title":"Existence of a p-glycoprotein drug efflux pump in cultured rabbit conjunctival epithelial cells","volume":"39","author":"Saha","year":"1998","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.mtbio.2025.102537_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2019.115356","article-title":"Functional chitosan oligosaccharide nanomicelles for topical ocular drug delivery of dexamethasone","volume":"227","author":"Xu","year":"2020","journal-title":"Carbohydr. Polym."},{"issue":"1\u20132","key":"10.1016\/j.mtbio.2025.102537_bib31","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ijpharm.2009.05.028","article-title":"Polyhydroxyethylaspartamide-based micelles for ocular drug delivery","volume":"378","author":"Civiale","year":"2009","journal-title":"Int J Pharm"},{"issue":"6","key":"10.1016\/j.mtbio.2025.102537_bib32","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1089\/108076802321021108","article-title":"In vitro human scleral permeability of fluorescein, dexamethasone-fluorescein, methotrexate-fluorescein and rhodamine 6G and the use of a coated coil as a new drug delivery system","volume":"18","author":"Cruysberg","year":"2002","journal-title":"J Ocul Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.mtbio.2025.102537_bib33","first-page":"1181","article-title":"Diffusion of high molecular weight compounds through sclera","volume":"41","author":"Ambati","year":"2000","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"2","key":"10.1016\/j.mtbio.2025.102537_bib34","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.exer.2005.08.009","article-title":"The sclera and myopia","volume":"82","author":"Rada","year":"2006","journal-title":"Exp. Eye Res."},{"issue":"3","key":"10.1016\/j.mtbio.2025.102537_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12030269","article-title":"Drug delivery to the posterior segment of the eye: biopharmaceutic and pharmacokinetic considerations","volume":"12","author":"Varela-Fern\u00e1ndez","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.mtbio.2025.102537_bib36","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1159\/000455276","article-title":"Drug delivery to the posterior segment of the eye","volume":"58","author":"Moisseiev","year":"2017","journal-title":"Dev. Ophthalmol."},{"issue":"2","key":"10.1016\/j.mtbio.2025.102537_bib37","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.preteyeres.2009.12.002","article-title":"The multifunctional choroid","volume":"29","author":"Nickla","year":"2010","journal-title":"Prog. Retin. Eye Res."},{"issue":"6","key":"10.1016\/j.mtbio.2025.102537_bib38","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.exer.2010.02.013","article-title":"Macromolecular diffusion characteristics of ageing human Bruch's membrane: implications for age-related macular degeneration (AMD)","volume":"90","author":"Hussain","year":"2010","journal-title":"Exp. Eye Res."},{"issue":"1","key":"10.1016\/j.mtbio.2025.102537_bib39","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1167\/iovs.07-0214","article-title":"Effect of eye pigmentation on transscleral drug delivery","volume":"49","author":"Cheruvu","year":"2008","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"3","key":"10.1016\/j.mtbio.2025.102537_bib40","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1208\/s12249-014-0244-2","article-title":"Nanomicellar topical aqueous drop formulation of rapamycin for back-of-the-eye delivery","volume":"16","author":"Cholkar","year":"2015","journal-title":"AAPS PharmSciTech"},{"issue":"4","key":"10.1016\/j.mtbio.2025.102537_bib41","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1089\/jop.2014.0152","article-title":"Development and evaluation of dexamethasone nanomicelles with potential for treating posterior uveitis after topical application","volume":"31","author":"Patel","year":"2015","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.mtbio.2025.102537_bib42","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.preteyeres.2012.10.004","article-title":"A contemporary concept of the blood-aqueous barrier","volume":"32","author":"Freddo","year":"2013","journal-title":"Prog. Retin. Eye Res."},{"issue":"Suppl 6","key":"10.1016\/j.mtbio.2025.102537_bib43","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.5301\/EJO.2010.6049","article-title":"Blood-retinal barrier","volume":"21","author":"Cunha-Vaz","year":"2011","journal-title":"Eur. J. Ophthalmol."},{"issue":"11","key":"10.1016\/j.mtbio.2025.102537_bib44","first-page":"2423","article-title":"Astrocytes increase barrier properties and ZO-1 expression in retinal vascular endothelial cells","volume":"38","author":"Gardner","year":"1997","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.mtbio.2025.102537_bib45","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/978-1-60761-938-3_5","article-title":"The blood-retinal barrier: structure and functional significance","volume":"686","author":"Runkle","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.mtbio.2025.102537_bib46","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.addr.2017.12.008","article-title":"Implications of melanin binding in ocular drug delivery","volume":"126","author":"Rimpel\u00e4","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.mtbio.2025.102537_bib47","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1167\/iovs.04-0925","article-title":"Functional characterization and comparison of the outer blood-retina barrier and the blood-brain barrier","volume":"46","author":"Steuer","year":"2005","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"6","key":"10.1016\/j.mtbio.2025.102537_bib48","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1021\/acs.molpharmaceut.7b00128","article-title":"Topical formulation of self-assembled antiviral prodrug nanomicelles for targeted retinal delivery","volume":"14","author":"Mandal","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.mtbio.2025.102537_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120226","article-title":"Safety assessment of polymeric micelles as an ophthalmic drug delivery system for intravitreal administration of dasatinib","volume":"596","author":"Li","year":"2021","journal-title":"Int J Pharm"},{"issue":"4","key":"10.1016\/j.mtbio.2025.102537_bib50","doi-asserted-by":"crossref","first-page":"E820","DOI":"10.1208\/aapsj070479","article-title":"Ophthalmic drug design based on the metabolic activity of the eye: soft drugs and chemical delivery systems","volume":"7","author":"Bodor","year":"2005","journal-title":"AAPS J."},{"issue":"4","key":"10.1016\/j.mtbio.2025.102537_bib51","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/jps.2600690407","article-title":"Effect of particle size on ophthalmic bioavailability of dexamethasone suspensions in rabbits","volume":"69","author":"Schoenwald","year":"1980","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.mtbio.2025.102537_bib52","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejps.2014.05.020","article-title":"Proniosome-derived niosomes for tacrolimus topical ocular delivery: in vitro cornea permeation, ocular irritation, and in vivo anti-allograft rejection","volume":"62","author":"Li","year":"2014","journal-title":"Eur J Pharm Sci"},{"issue":"6","key":"10.1016\/j.mtbio.2025.102537_bib53","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0039-6257(93)90141-S","article-title":"Minimizing systemic absorption of topically administered ophthalmic drugs","volume":"37","author":"Urtti","year":"1993","journal-title":"Surv. Ophthalmol."},{"issue":"2","key":"10.1016\/j.mtbio.2025.102537_bib54","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1517\/13543776.2016.1131267","article-title":"Topical drug delivery systems: a patent review","volume":"26","author":"Singh Malik","year":"2016","journal-title":"Expert Opin. Ther. Pat."},{"issue":"1","key":"10.1016\/j.mtbio.2025.102537_bib55","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1089\/jop.1994.10.29","article-title":"Microparticulates for ophthalmic drug delivery","volume":"10","author":"Joshi","year":"1994","journal-title":"J. Ocul. Pharmacol."},{"issue":"31","key":"10.1016\/j.mtbio.2025.102537_bib56","first-page":"1259","article-title":"The effect of vehicle composition on the release of chloramphenicol from creams and eye ointments","volume":"49","author":"McCarthy","year":"1975","journal-title":"S. Afr. Med. J."},{"issue":"1","key":"10.1016\/j.mtbio.2025.102537_bib57","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/0192623307310955","article-title":"Safety evaluation of ocular drug delivery formulations: techniques and practical considerations","volume":"36","author":"Short","year":"2008","journal-title":"Toxicol. Pathol."},{"issue":"13","key":"10.1016\/j.mtbio.2025.102537_bib58","first-page":"5816","article-title":"Efficacy of a topical ocular drug delivery device (TODDD) for the treatment of glaucoma by telemetric measurement of IOP in the normal rabbit","volume":"48","author":"Leahy","year":"2007","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"10","key":"10.1016\/j.mtbio.2025.102537_bib59","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1007\/s00417-008-0875-7","article-title":"Side effects of commonly used glaucoma medications: comparison of tolerability, chance of discontinuation, and patient satisfaction","volume":"246","author":"Beckers","year":"2008","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.mtbio.2025.102537_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2020.100901","article-title":"Extraocular, periocular, and intraocular routes for sustained drug delivery for glaucoma","volume":"82","author":"Kompella","year":"2021","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.mtbio.2025.102537_bib61","first-page":"214","article-title":"Hydroxypropyl cellulose ophthalmic inserts (lacrisert) reduce the signs and symptoms of dry eye syndrome and improve patient quality of life","volume":"107","author":"McDonald","year":"2009","journal-title":"Trans. Am. Ophthalmol. Soc."},{"key":"10.1016\/j.mtbio.2025.102537_bib62","series-title":"Nguyen, Review of Hydroxypropyl Cellulose Ophthalmic Inserts for Treatment of Dry Eye","author":"Latkany","year":"2011"},{"issue":"2","key":"10.1016\/j.mtbio.2025.102537_bib63","doi-asserted-by":"crossref","first-page":"E15","DOI":"10.1208\/ps050215","article-title":"Functional differences in nucleoside and nucleobase transporters expressed on the rabbit corneal epithelial cell line (SIRC) and isolated rabbit cornea","volume":"5","author":"Majumdar","year":"2003","journal-title":"AAPS PharmSci"},{"issue":"11","key":"10.1016\/j.mtbio.2025.102537_bib64","doi-asserted-by":"crossref","first-page":"4877","DOI":"10.1167\/iovs.02-1108","article-title":"Distribution of rat organic anion transporting polypeptide-E (oatp-E) in the rat eye","volume":"44","author":"Ito","year":"2003","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.mtbio.2025.102537_bib65","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/9312340","article-title":"Comprehensive review of the literature on existing punctal plugs for the management of dry eye disease","volume":"2016","author":"Jehangir","year":"2016","journal-title":"J Ophthalmol"},{"issue":"8","key":"10.1016\/j.mtbio.2025.102537_bib66","first-page":"1825","article-title":"Results of a phase 3, randomized, double-masked, vehicle controlled study (phase 3c) evaluating the safety and efficacy of DEXTENZATM (dexamethasone insert) 0.4 mg for the treatment of ocular inflammation and pain after cataract surgery","volume":"58","author":"Talamo","year":"2017","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"3","key":"10.1016\/j.mtbio.2025.102537_bib68","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.exer.2010.05.022","article-title":"Ocular pharmacokinetic study of a corticosteroid by 19F MR","volume":"91","author":"Liu","year":"2010","journal-title":"Exp. Eye Res."},{"issue":"6","key":"10.1016\/j.mtbio.2025.102537_bib69","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/jps.2600680606","article-title":"Mechanistic and quantitative evaluation of precorneal pilocarpine disposition in albino rabbits","volume":"68","author":"Lee","year":"1979","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.mtbio.2025.102537_bib70","first-page":"259","article-title":"Porcine sclera as a model of human sclera for in vitro transport experiments: histology, SEM, and comparative permeability","volume":"15","author":"Nicoli","year":"2009","journal-title":"Mol. Vis."},{"issue":"10","key":"10.1016\/j.mtbio.2025.102537_bib71","doi-asserted-by":"crossref","first-page":"5205","DOI":"10.1167\/iovs.10-5337","article-title":"Evaluation of clearance mechanisms with transscleral drug delivery","volume":"51","author":"Lee","year":"2010","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"4","key":"10.1016\/j.mtbio.2025.102537_bib72","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.exer.2010.01.001","article-title":"Episcleral clearance of sodium fluorescein from a bioerodible sub-tenon's implant in the rat","volume":"90","author":"Chan","year":"2010","journal-title":"Exp. Eye Res."},{"issue":"4","key":"10.1016\/j.mtbio.2025.102537_bib73","doi-asserted-by":"crossref","first-page":"693","DOI":"10.22270\/jddt.v9i4.3207","article-title":"Ocular inserts - a novel approach in ocular drug delivery","volume":"9","author":"Khan","year":"2019","journal-title":"J. Drug Deliv. Therapeut."},{"issue":"12","key":"10.1016\/j.mtbio.2025.102537_bib74","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.4155\/tde.14.75","article-title":"Advances in ophthalmic drug delivery","volume":"5","author":"Morrison","year":"2014","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.mtbio.2025.102537_bib75","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1097\/IJG.0000000000002618","article-title":"Exposure of PreserFlo microshunt: risk factors and surgical management","author":"Morales-Fern\u00e1ndez","year":"2025","journal-title":"J. Glaucoma"},{"key":"10.1016\/j.mtbio.2025.102537_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120452","article-title":"Gelatine-based drug-eluting bandage contact lenses: effect of PEGDA concentration and manufacturing technique","volume":"599","author":"Zidan","year":"2021","journal-title":"Int J Pharm"},{"issue":"1 Suppl","key":"10.1016\/j.mtbio.2025.102537_bib77","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1097\/00140068-200301001-00011","article-title":"Contact lens chemistry and giant papillary conjunctivitis","volume":"29","author":"Donshik","year":"2003","journal-title":"Eye Contact Lens"},{"issue":"1","key":"10.1016\/j.mtbio.2025.102537_bib78","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/ICU.0b013e3282f30577","article-title":"Perioperative antibiotics and anti-inflammatory agents in cataract surgery","volume":"19","author":"DeCroos","year":"2008","journal-title":"Curr. Opin. Ophthalmol."},{"issue":"2","key":"10.1016\/j.mtbio.2025.102537_bib79","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jconrel.2011.06.011","article-title":"Design of multi-drug release coatings targeting infection and inflammation","volume":"155","author":"Shukla","year":"2011","journal-title":"J Control Release"},{"issue":"6","key":"10.1016\/j.mtbio.2025.102537_bib80","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.mser.2010.05.002","article-title":"Polymers in modern ophthalmic implants\u2014Historical background and recent advances","volume":"69","author":"Bozukova","year":"2010","journal-title":"Mater. Sci. Eng. R Rep."},{"issue":"14","key":"10.1016\/j.mtbio.2025.102537_bib81","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/j.addr.2005.08.006","article-title":"Recent progress in ocular drug delivery for posterior segment disease: emphasis on transscleral iontophoresis","volume":"57","author":"Myles","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"8","key":"10.1016\/j.mtbio.2025.102537_bib82","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1089\/jop.2012.0175","article-title":"Evaluation of ocular and general safety following repeated dosing of dexamethasone phosphate delivered by transscleral iontophoresis in rabbits","volume":"29","author":"Patane","year":"2013","journal-title":"J Ocul Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.mtbio.2025.102537_bib83","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/s11095-009-0042-9","article-title":"New techniques for drug delivery to the posterior eye segment","volume":"27","author":"Eljarrat-Binstock","year":"2010","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.mtbio.2025.102537_bib84","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13010028","article-title":"Novel drug delivery systems fighting glaucoma: formulation obstacles and solutions","volume":"13","author":"Rahi\u0107","year":"2020","journal-title":"Pharmaceutics"},{"issue":"5","key":"10.1016\/j.mtbio.2025.102537_bib85","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S0161-6420(89)32832-6","article-title":"Transscleral and transcorneal iontophoresis of ketoconazole in the rabbit eye","volume":"96","author":"Grossman","year":"1989","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.mtbio.2025.102537_bib86","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1163\/156856204323005271","article-title":"Hydrogel probe for iontophoresis drug delivery to the eye","volume":"15","author":"Eljarrat-Binstock","year":"2004","journal-title":"J. Biomater. Sci. Polym. Ed."},{"issue":"3","key":"10.1016\/j.mtbio.2025.102537_bib87","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3109\/02713680903521936","article-title":"Mini drug pump for ophthalmic use","volume":"35","author":"Saati","year":"2010","journal-title":"Curr. Eye Res."},{"issue":"4","key":"10.1016\/j.mtbio.2025.102537_bib88","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/00003226-200305000-00013","article-title":"Corneal endothelial cell damage from glaucoma drainage device materials","volume":"22","author":"Lim","year":"2003","journal-title":"Cornea"},{"key":"10.1016\/j.mtbio.2025.102537_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114463","article-title":"The in vivo fate of polymeric micelles","volume":"188","author":"Cai","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1\u20133","key":"10.1016\/j.mtbio.2025.102537_bib90","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jconrel.2005.09.034","article-title":"Block copolymer micelles: preparation, characterization and application in drug delivery","volume":"109","author":"Gaucher","year":"2005","journal-title":"J Control Release"},{"issue":"47","key":"10.1016\/j.mtbio.2025.102537_bib91","doi-asserted-by":"crossref","first-page":"8920","DOI":"10.1039\/D2SM01320G","article-title":"Determination of the critical micelle concentration of surfactants using fluorescence strategies","volume":"18","author":"Wu","year":"2022","journal-title":"Soft Matter"},{"issue":"1","key":"10.1016\/j.mtbio.2025.102537_bib92","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1049\/nbt2.12018","article-title":"Nanomicelles: types, properties and applications in drug delivery","volume":"15","author":"Bose","year":"2021","journal-title":"IET Nanobiotechnol."},{"issue":"4","key":"10.1016\/j.mtbio.2025.102537_bib93","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1080\/17425247.2019.1597848","article-title":"Topical application of polymeric nanomicelles in ophthalmology: a review on research efforts for the noninvasive delivery of ocular therapeutics","volume":"16","author":"Grimaudo","year":"2019","journal-title":"Expert Opin Drug Deliv"},{"issue":"24","key":"10.1016\/j.mtbio.2025.102537_bib94","doi-asserted-by":"crossref","first-page":"11951","DOI":"10.1021\/jp202335r","article-title":"Near-critical fluid micellization for high and efficient drug loading: encapsulation of paclitaxel into PEG-b-PCL micelles","volume":"115","author":"Tyrrell","year":"2011","journal-title":"J. Phys. Chem. C"},{"key":"10.1016\/j.mtbio.2025.102537_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2021.118006","article-title":"Hyaluronic acid in ocular drug delivery","volume":"264","author":"Zhang","year":"2021","journal-title":"Carbohydr. Polym."},{"issue":"5","key":"10.1016\/j.mtbio.2025.102537_bib96","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1039\/C9BM01754B","article-title":"Thermogelling chitosan-based polymers for the treatment of oral mucosa ulcers","volume":"8","author":"Luo","year":"2020","journal-title":"Biomater. Sci."},{"issue":"11","key":"10.1016\/j.mtbio.2025.102537_bib97","doi-asserted-by":"crossref","DOI":"10.3390\/polym8110367","article-title":"Synthesis of novel Temperature- and pH-Sensitive ABA triblock copolymers P(DEAEMA-co-MEO2MA-co-OEGMA)-b-PEG-b-P(DEAEMA-co-MEO2MA-co-OEGMA): micellization, sol-gel transitions, and sustained BSA release","volume":"8","author":"Han","year":"2016","journal-title":"Polymers"},{"issue":"3","key":"10.1016\/j.mtbio.2025.102537_bib98","first-page":"365","article-title":"Polymeric Micelles in Ocular Drug Delivery: Rationale, Strategies and Challenges","volume":"26","author":"Pepi\u0107","year":"2012","journal-title":"Chemical and Biochemical Engineering Quarterly"},{"issue":"5","key":"10.1016\/j.mtbio.2025.102537_bib99","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.nano.2011.01.017","article-title":"Synergistic encapsulation of the anti-HIV agent efavirenz within mixed poloxamine\/poloxamer polymeric micelles","volume":"7","author":"Chiappetta","year":"2011","journal-title":"Nanomedicine"},{"issue":"2\u20133","key":"10.1016\/j.mtbio.2025.102537_bib100","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0168-3659(98)00054-6","article-title":"Incorporation of water-insoluble anticancer drug into polymeric micelles and control of their particle size","volume":"55","author":"Yokoyama","year":"1998","journal-title":"J Control Release"},{"key":"10.1016\/j.mtbio.2025.102537_bib101","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jconrel.2021.02.031","article-title":"Polymeric micelles in drug delivery: an insight of the techniques for their characterization and assessment in biorelevant conditions","volume":"332","author":"Ghezzi","year":"2021","journal-title":"J Control Release"},{"issue":"2","key":"10.1016\/j.mtbio.2025.102537_bib102","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF02976666","article-title":"A polymeric micellar carrier for the solubilization of biphenyl dimethyl dicarboxylate","volume":"26","author":"Chi","year":"2003","journal-title":"Arch Pharm. Res. (Seoul)"},{"issue":"6","key":"10.1016\/j.mtbio.2025.102537_bib103","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1023\/B:PHAM.0000029284.40637.69","article-title":"A novel one-step drug-loading procedure for water-soluble amphiphilic nanocarriers","volume":"21","author":"Fournier","year":"2004","journal-title":"Pharm. Res."},{"issue":"2","key":"10.1016\/j.mtbio.2025.102537_bib104","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0928-0987(01)00221-4","article-title":"Practical aspects of lyophilization using non-aqueous co-solvent systems","volume":"15","author":"Teagarden","year":"2002","journal-title":"Eur J Pharm Sci"},{"issue":"2","key":"10.1016\/j.mtbio.2025.102537_bib105","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ejpb.2004.03.003","article-title":"In situ forming parenteral drug delivery systems: an overview","volume":"58","author":"Packhaeuser","year":"2004","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"7","key":"10.1016\/j.mtbio.2025.102537_bib106","doi-asserted-by":"crossref","DOI":"10.1002\/mabi.201600444","article-title":"Novel anti-biofouling soft contact lens: L-cysteine conjugated amphiphilic conetworks via RAFT and thiol-ene click chemistry","volume":"17","author":"Zhang","year":"2017","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.mtbio.2025.102537_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2021.105735","article-title":"A grafted copolymer-based nanomicelles for topical ocular delivery of everolimus: formulation, characterization, ex-vivo permeation, in-vitro ocular toxicity, and stability study","volume":"159","author":"Mehra","year":"2021","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.mtbio.2025.102537_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119120","article-title":"Bile acid transporter mediated STC\/soluplus self-assembled hybrid nanoparticles for enhancing the oral drug bioavailability","volume":"579","author":"Zhang","year":"2020","journal-title":"Int J Pharm"},{"key":"10.1016\/j.mtbio.2025.102537_bib109","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.addr.2020.09.009","article-title":"Polymeric micelles for the delivery of poorly soluble drugs: from nanoformulation to clinical approval","volume":"156","author":"Hwang","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"10","key":"10.1016\/j.mtbio.2025.102537_bib110","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S1359-6446(02)02255-9","article-title":"Hydrogels: from controlled release to pH-responsive drug delivery","volume":"7","author":"Gupta","year":"2002","journal-title":"Drug Discov. Today"},{"issue":"8","key":"10.1016\/j.mtbio.2025.102537_bib111","doi-asserted-by":"crossref","first-page":"947","DOI":"10.2174\/1389450122999210128180058","article-title":"Recent progress in stimuli-responsive intelligent nano scale drug delivery systems: a special focus towards pH-Sensitive systems","volume":"22","author":"Sethuraman","year":"2021","journal-title":"Curr. Drug Targets"},{"issue":"21","key":"10.1016\/j.mtbio.2025.102537_bib112","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201800623","article-title":"Sustained and bioresponsive two-stage delivery of therapeutic miRNA via polyplex micelle-loaded injectable hydrogels for inhibition of intervertebral disc fibrosis","volume":"7","author":"Feng","year":"2018","journal-title":"Adv Healthc Mater"},{"issue":"8","key":"10.1016\/j.mtbio.2025.102537_bib113","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1021\/acsabm.9b00467","article-title":"PHA-based thermogel as a controlled zero-order chemotherapeutic delivery system for the effective treatment of melanoma","volume":"2","author":"Jiang","year":"2019","journal-title":"ACS Appl. Bio Mater."},{"issue":"1","key":"10.1016\/j.mtbio.2025.102537_bib114","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1080\/10717544.2020.1748759","article-title":"Localized co-delivery of CNTF and FK506 using a thermosensitive hydrogel for retina ganglion cells protection after traumatic optic nerve injury","volume":"27","author":"Wang","year":"2020","journal-title":"Drug Deliv."},{"key":"10.1016\/j.mtbio.2025.102537_bib115","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.jconrel.2023.08.041","article-title":"An insight on ophthalmic drug delivery systems: focus on polymeric biomaterials-based carriers","volume":"362","author":"Shafiq","year":"2023","journal-title":"J Control Release"},{"key":"10.1016\/j.mtbio.2025.102537_bib116","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ijpharm.2019.06.008","article-title":"Plackett-burman design for screening of critical variables and their effects on the optical transparency and swelling of gatifloxacin-pluronic-loaded contact lens","volume":"566","author":"Maulvi","year":"2019","journal-title":"Int J Pharm"},{"key":"10.1016\/j.mtbio.2025.102537_bib117","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jconrel.2019.05.025","article-title":"Co-delivery of latanoprost and timolol from micelles-laden contact lenses for the treatment of glaucoma","volume":"305","author":"Xu","year":"2019","journal-title":"J Control Release"},{"issue":"3","key":"10.1016\/j.mtbio.2025.102537_bib118","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jtos.2017.05.005","article-title":"TFOS DEWS II introduction","volume":"15","author":"Nelson","year":"2017","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.mtbio.2025.102537_bib119","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.colsurfb.2015.11.059","article-title":"Pimecrolimus micelle exhibits excellent therapeutic effect for keratoconjunctivitis sicca","volume":"140","author":"Yingfang","year":"2016","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"1","key":"10.1016\/j.mtbio.2025.102537_bib120","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1080\/10717544.2019.1622608","article-title":"New micelle myricetin formulation for ocular delivery: improved stability, solubility, and ocular anti-inflammatory treatment","volume":"26","author":"Sun","year":"2019","journal-title":"Drug Deliv."},{"issue":"29","key":"10.1016\/j.mtbio.2025.102537_bib121","doi-asserted-by":"crossref","first-page":"16578","DOI":"10.1039\/C9RA02858G","article-title":"Drug-eluting contact lens containing cyclosporine-loaded cholesterol-hyaluronate micelles for dry eye syndrome","volume":"9","author":"Mun","year":"2019","journal-title":"RSC Adv."},{"issue":"1","key":"10.1016\/j.mtbio.2025.102537_bib122","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1080\/10717544.2018.1458923","article-title":"Improving the topical ocular pharmacokinetics of lyophilized cyclosporine A-loaded micelles: formulation, in vitro and in vivo studies","volume":"25","author":"Yu","year":"2018","journal-title":"Drug Deliv."},{"key":"10.1016\/j.mtbio.2025.102537_bib123","doi-asserted-by":"crossref","first-page":"8281","DOI":"10.2147\/IJN.S173691","article-title":"Stability, safety, and transcorneal mechanistic studies of ophthalmic lyophilized cyclosporine-loaded polymeric micelles","volume":"13","author":"Shen","year":"2018","journal-title":"Int J Nanomedicine"},{"issue":"7","key":"10.1016\/j.mtbio.2025.102537_bib124","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1089\/jop.2018.0106","article-title":"Ocular distribution of cyclosporine following topical administration of OTX-101 in New Zealand white rabbits","volume":"35","author":"Weiss","year":"2019","journal-title":"J Ocul Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.mtbio.2025.102537_bib125","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1089\/jop.2018.0154","article-title":"Effect of OTX-101, a novel nanomicellar formulation of cyclosporine A, on conjunctival staining in patients with keratoconjunctivitis sicca: a pooled analysis of phase 2b\/3 and 3 clinical trials","volume":"35","author":"Smyth-Medina","year":"2019","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.mtbio.2025.102537_bib126","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2021.106020","article-title":"Preparation and characterization of a naringenin solubilizing glycyrrhizin nanomicelle ophthalmic solution for experimental dry eye disease","volume":"167","author":"Li","year":"2021","journal-title":"Eur J Pharm Sci"},{"issue":"10","key":"10.1016\/j.mtbio.2025.102537_bib127","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.18240\/ijo.2025.10.01","article-title":"N-acylethanolamine acid amidase inhibitor-loaded polymeric micelles in the treatment of dry eye disease","volume":"18","author":"Zhao","year":"2025","journal-title":"Int. J. Ophthalmol."},{"issue":"17","key":"10.1016\/j.mtbio.2025.102537_bib128","article-title":"Anti-oxidative and anti-inflammatory micelles: break the dry eye vicious cycle","volume":"9","author":"Li","year":"2022","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"5","key":"10.1016\/j.mtbio.2025.102537_bib129","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1080\/02713683.2021.2022163","article-title":"Copolymer micelle-administered melatonin ameliorates hyperosmolarity-induced ocular surface damage through regulating PINK1-mediated mitophagy","volume":"47","author":"Xu","year":"2022","journal-title":"Curr. Eye Res."},{"issue":"1","key":"10.1016\/j.mtbio.2025.102537_bib130","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1099\/jmm.0.001110","article-title":"Pseudomonas aeruginosa and microbial keratitis","volume":"69","author":"Hilliam","year":"2020","journal-title":"J. Med. Microbiol."},{"issue":"3","key":"10.1016\/j.mtbio.2025.102537_bib131","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1021\/acscentsci.8b00850","article-title":"Promoting angiogenesis in oxidative diabetic wound microenvironment using a nanozyme-reinforced self-protecting hydrogel","volume":"5","author":"Wu","year":"2019","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.mtbio.2025.102537_bib132","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118986","article-title":"Micelle-nanogel platform for ferulic acid ocular delivery","volume":"576","author":"Grimaudo","year":"2020","journal-title":"Int J Pharm"},{"key":"10.1016\/j.mtbio.2025.102537_bib133","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2020.111157","article-title":"Preparation and in vitro-in vivo evaluation of novel ocular nanomicelle formulation of thymol based on glycyrrhizin","volume":"194","author":"Song","year":"2020","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"24","key":"10.1016\/j.mtbio.2025.102537_bib134","doi-asserted-by":"crossref","first-page":"4575","DOI":"10.1039\/D2TB00667G","article-title":"ROS-scavenging glyco-nanoplatform for synergistic antibacterial and wound-healing therapy of bacterial keratitis","volume":"10","author":"Zhang","year":"2022","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.mtbio.2025.102537_bib135","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2023.120822","article-title":"Chitosan-poly(lactide-co-glycolide)\/poloxamer mixed micelles as a mucoadhesive thermo-responsive moxifloxacin eye drop to improve treatment efficacy in bacterial keratitis","volume":"312","author":"Ch","year":"2023","journal-title":"Carbohydr. Polym."},{"issue":"1","key":"10.1016\/j.mtbio.2025.102537_bib136","doi-asserted-by":"crossref","first-page":"59","DOI":"10.18295\/2075-0528.2763","article-title":"A retrospective study of fungal corneal ulcers in the south sharqiyah region in Oman","volume":"9","author":"Idiculla","year":"2009","journal-title":"Sultan Qaboos Univ Med J"},{"issue":"9","key":"10.1016\/j.mtbio.2025.102537_bib137","doi-asserted-by":"crossref","first-page":"e307","DOI":"10.1016\/j.jfo.2017.08.001","article-title":"Fungal keratitis","volume":"40","author":"Bourcier","year":"2017","journal-title":"J. Fr. Ophtalmol."},{"issue":"1\u20132","key":"10.1016\/j.mtbio.2025.102537_bib138","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ijpharm.2018.08.001","article-title":"Optimization of \u03b2-cyclodextrin consolidated micellar dispersion for promoting the transcorneal permeation of a practically insoluble drug","volume":"549","author":"Sayed","year":"2018","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.mtbio.2025.102537_bib139","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1080\/10717544.2018.1497107","article-title":"Solutol HS15 based binary mixed micelles with penetration enhancers for augmented corneal delivery of sertaconazole nitrate: optimization, in vitro, ex vivo and in vivo characterization","volume":"25","author":"Younes","year":"2018","journal-title":"Drug Deliv."},{"issue":"5","key":"10.1016\/j.mtbio.2025.102537_bib140","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1016\/j.xphs.2020.12.013","article-title":"Voriconazole ternary micellar systems for the treatment of ocular mycosis: statistical optimization and in vivo evaluation","volume":"110","author":"Fahmy","year":"2021","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.mtbio.2025.102537_bib141","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.actbio.2021.10.047","article-title":"Mucoadhesive phenylboronic acid conjugated chitosan oligosaccharide-vitamin E copolymer for topical ocular delivery of voriconazole: synthesis, in vitro\/vivo evaluation, and mechanism","volume":"138","author":"Sun","year":"2022","journal-title":"Acta Biomater."},{"issue":"11","key":"10.1016\/j.mtbio.2025.102537_bib142","doi-asserted-by":"crossref","first-page":"6575","DOI":"10.1021\/acs.molpharmaceut.5c00423","article-title":"Biomimetic nanomicelles: utilizing peptide transporters to overcome corneal barrier for treating fungal infection","volume":"22","author":"Sathe","year":"2025","journal-title":"Mol. Pharm."},{"issue":"4","key":"10.1016\/j.mtbio.2025.102537_bib143","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/ICU.0000000000000483","article-title":"Management of Herpes simplex virus epithelial keratitis","volume":"29","author":"Roozbahani","year":"2018","journal-title":"Curr. Opin. Ophthalmol."},{"issue":"Suppl B","key":"10.1016\/j.mtbio.2025.102537_bib144","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/jac\/12.suppl_B.39","article-title":"Herpes simplex virus infections of the eye and their management with acyclovir","volume":"12","author":"Falcon","year":"1983","journal-title":"J. Antimicrob. Chemother."},{"issue":"1\u20132","key":"10.1016\/j.mtbio.2025.102537_bib145","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ijpharm.2018.09.053","article-title":"Soluplus micelles for acyclovir ocular delivery: formulation and cornea and sclera permeability","volume":"552","author":"Varela-Garcia","year":"2018","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.mtbio.2025.102537_bib146","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1089\/jop.2013.0157","article-title":"Aqueous nanomicellar formulation for topical delivery of biotinylated lipid prodrug of acyclovir: formulation development and ocular biocompatibility","volume":"30","author":"Vadlapudi","year":"2014","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.mtbio.2025.102537_bib147","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2024.114351","article-title":"Nanoparticle-hydrogel composite as dual-drug delivery system for the potential application of corneal graft rejection","volume":"201","author":"Xu","year":"2024","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"2","key":"10.1016\/j.mtbio.2025.102537_bib148","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1021\/acs.molpharmaceut.7b00939","article-title":"Poloxamer 407\/TPGS mixed micelles as promising carriers for cyclosporine ocular delivery","volume":"15","author":"Grimaudo","year":"2018","journal-title":"Mol. Pharm."},{"issue":"2","key":"10.1016\/j.mtbio.2025.102537_bib149","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ejpb.2012.02.014","article-title":"Novel micelle carriers for cyclosporin A topical ocular delivery: in vivo cornea penetration, ocular distribution and efficacy studies","volume":"81","author":"Di Tommaso","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"2","key":"10.1016\/j.mtbio.2025.102537_bib150","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ijpharm.2011.01.004","article-title":"Ocular biocompatibility of novel cyclosporin A formulations based on methoxy poly(ethylene glycol)-hexylsubstituted poly(lactide) micelle carriers","volume":"416","author":"Di Tommaso","year":"2011","journal-title":"Int J Pharm"},{"issue":"4","key":"10.1016\/j.mtbio.2025.102537_bib151","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/ajt.13151","article-title":"Evolving perspectives of mTOR complexes in immunity and transplantation","volume":"15","author":"Fantus","year":"2015","journal-title":"Am. J. Transplant."},{"issue":"1","key":"10.1016\/j.mtbio.2025.102537_bib152","doi-asserted-by":"crossref","DOI":"10.3390\/jfb14010049","article-title":"Characterization and evaluation of rapamycin-loaded nano-micelle ophthalmic solution","volume":"14","author":"Zhang","year":"2023","journal-title":"J. Funct. Biomater."},{"key":"10.1016\/j.mtbio.2025.102537_bib153","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.3389\/fimmu.2018.02283","article-title":"Rapamycin nano-micelle ophthalmic solution reduces corneal allograft rejection by potentiating myeloid-derived suppressor cells' function","volume":"9","author":"Wei","year":"2018","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.mtbio.2025.102537_bib154","first-page":"309","article-title":"Cataract surgery: from today's standards to future progress","volume":"6","author":"Alio","year":"2017","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"issue":"2","key":"10.1016\/j.mtbio.2025.102537_bib155","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1021\/acsbiomaterials.8b01089","article-title":"PLA-PEG micelles loaded with a classic vasodilator for oxidative cataract prevention","volume":"5","author":"Xu","year":"2019","journal-title":"ACS Biomater. Sci. Eng."},{"issue":"1","key":"10.1016\/j.mtbio.2025.102537_bib156","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2174\/2667387816666220128123737","article-title":"Development of bromfenac sodium loaded pluronic nanomicelles: characterization and corneal permeation study","volume":"16","author":"Patel","year":"2022","journal-title":"Recent Adv Drug Deliv Formul"},{"issue":"74","key":"10.1016\/j.mtbio.2025.102537_bib157","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1098\/rsif.2012.0102","article-title":"Single and mixed poloxamine micelles as nanocarriers for solubilization and sustained release of ethoxzolamide for topical glaucoma therapy","volume":"9","author":"Ribeiro","year":"2012","journal-title":"J R Soc Interface"},{"issue":"3","key":"10.1016\/j.mtbio.2025.102537_bib158","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s13346-020-00834-0","article-title":"Rebaudioside A\/TPGS mixed nanomicelles as promising nanocarriers for nimodipine ocular delivery","volume":"11","author":"Li","year":"2021","journal-title":"Drug Deliv Transl Res"},{"key":"10.1016\/j.mtbio.2025.102537_bib159","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.2147\/OPTH.S266453","article-title":"Physiochemical properties and cytotoxicity of a benzalkonium chloride-free, micellar emulsion ophthalmic formulation of latanoprost","volume":"14","author":"Halder","year":"2020","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.mtbio.2025.102537_bib160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2024.114208","article-title":"Combination of self-assembling system and N,O-Carboxymethyl chitosan improves ocular residence of anti-glaucoma drug","volume":"197","author":"Kailasam","year":"2024","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"43","key":"10.1016\/j.mtbio.2025.102537_bib161","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202004205","article-title":"Targeted delivery of cell softening micelles to schlemm's canal endothelial cells for treatment of glaucoma","volume":"16","author":"Stack","year":"2020","journal-title":"Small"},{"issue":"43","key":"10.1016\/j.mtbio.2025.102537_bib162","doi-asserted-by":"crossref","first-page":"10433","DOI":"10.1039\/D3TB01430D","article-title":"Reduction-responsive polymeric micelles for trans-corneal targeted delivery of microRNA-21-5p and glaucoma-specific gene therapy","volume":"11","author":"Han","year":"2023","journal-title":"J. Mater. Chem. B"},{"issue":"3","key":"10.1016\/j.mtbio.2025.102537_bib163","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s11095-024-03672-8","article-title":"Co-delivery of brinzolamide and timolol from micelles-laden contact lenses: in vitro and in vivo evaluation","volume":"41","author":"Yang","year":"2024","journal-title":"Pharm. Res."},{"issue":"3","key":"10.1016\/j.mtbio.2025.102537_bib164","doi-asserted-by":"crossref","first-page":"301","DOI":"10.4155\/fmc.12.206","article-title":"Microvascular complications and diabetic retinopathy: recent advances and future implications","volume":"5","author":"Barot","year":"2013","journal-title":"Future Med. Chem."},{"issue":"3","key":"10.1016\/j.mtbio.2025.102537_bib165","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/ICU.0000000000000850","article-title":"Complications of intravitreal injections: 2022","volume":"33","author":"Patel","year":"2022","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.mtbio.2025.102537_bib166","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122081","article-title":"An injectable thermosensitive hydrogel for dual delivery of diclofenac and avastin\u00ae to effectively suppress inflammatory corneal neovascularization","volume":"625","author":"Shi","year":"2022","journal-title":"Int J Pharm"},{"issue":"11","key":"10.1016\/j.mtbio.2025.102537_bib167","doi-asserted-by":"crossref","first-page":"5031","DOI":"10.1021\/acs.molpharmaceut.8b00620","article-title":"Imatinib-loaded micelles of hyaluronic acid derivatives for potential treatment of neovascular ocular diseases","volume":"15","author":"Bongiov\u00ec","year":"2018","journal-title":"Mol. Pharm."},{"issue":"23","key":"10.1016\/j.mtbio.2025.102537_bib168","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1039\/D0TB00874E","article-title":"Development of mucoadhesive cationic polypeptide micelles for sustained cabozantinib release and inhibition of corneal neovascularization","volume":"8","author":"Han","year":"2020","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.mtbio.2025.102537_bib169","first-page":"1163","article-title":"Celastrol nanoparticles inhibit corneal neovascularization induced by suturing in rats","volume":"7","author":"Li","year":"2012","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.mtbio.2025.102537_bib170","doi-asserted-by":"crossref","first-page":"6135","DOI":"10.2147\/IJN.S117425","article-title":"Celastrol nanomicelles attenuate cytokine secretion in macrophages and inhibit macrophage-induced corneal neovascularization in rats","volume":"11","author":"Li","year":"2016","journal-title":"Int J Nanomedicine"},{"issue":"2","key":"10.1016\/j.mtbio.2025.102537_bib171","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.apsb.2023.09.001","article-title":"pH-Responsive polymer boosts cytosolic siRNA release for retinal neovascularization therapy","volume":"14","author":"Guo","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.mtbio.2025.102537_bib172","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c4976","article-title":"Investigation and management of uveitis","volume":"341","author":"Guly","year":"2010","journal-title":"Bmj"},{"issue":"2","key":"10.1016\/j.mtbio.2025.102537_bib173","first-page":"153","article-title":"Preparation and evaluation of PCL-PEG-PCL micelles as potential nanocarriers for ocular delivery of dexamethasone","volume":"21","author":"Alami-Milani","year":"2018","journal-title":"Iran J Basic Med Sci"},{"issue":"6","key":"10.1016\/j.mtbio.2025.102537_bib174","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1080\/10837450.2020.1733606","article-title":"PLA-PCL-PEG-PCL-PLA based micelles for improving the ocular permeability of dexamethasone: development, characterization, and in vitro evaluation","volume":"25","author":"Alami-Milani","year":"2020","journal-title":"Pharm Dev Technol"},{"issue":"5","key":"10.1016\/j.mtbio.2025.102537_bib175","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1208\/s12248-025-01103-z","article-title":"A nanomicelles platform delivery system for water-insoluble corticosteroid to treat anterior uveitis","volume":"27","author":"Sathe","year":"2025","journal-title":"AAPS J."},{"issue":"1","key":"10.1016\/j.mtbio.2025.102537_bib176","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1080\/10717544.2020.1797241","article-title":"Polymeric micelles for the ocular delivery of triamcinolone acetonide: preparation and in vivo evaluation in a rabbit ocular inflammatory model","volume":"27","author":"Safwat","year":"2020","journal-title":"Drug Deliv."},{"key":"10.1016\/j.mtbio.2025.102537_bib177","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.126162","article-title":"Therapeutic potential of phosphodiesterase inhibitor-loaded nanomicelles to treat endotoxin-induced anterior uveitis","volume":"684","author":"Kailasam","year":"2025","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1016\/j.mtbio.2025.102537_bib178","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1177\/0883073815587943","article-title":"Retinoblastoma","volume":"31","author":"Ortiz","year":"2016","journal-title":"J. Child Neurol."},{"issue":"1","key":"10.1016\/j.mtbio.2025.102537_bib179","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1080\/10717544.2020.1730522","article-title":"Effectively suppressed angiogenesis-mediated retinoblastoma growth using celastrol nanomicelles","volume":"27","author":"Li","year":"2020","journal-title":"Drug Deliv."},{"issue":"10","key":"10.1016\/j.mtbio.2025.102537_bib180","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1166\/jbn.2020.2983","article-title":"Antiangiogenic and antitumor therapy for retinoblastoma with hypoxia-inducible Factor-1\u03b1 siRNA and celastrol Co-Delivery nanomicelles","volume":"16","author":"Yang","year":"2020","journal-title":"J. Biomed. Nanotechnol."},{"issue":"5","key":"10.1016\/j.mtbio.2025.102537_bib181","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1089\/jop.2010.0048","article-title":"In vitro evaluation of a targeted and sustained release system for retinoblastoma cells using doxorubicin as a model drug","volume":"26","author":"Boddu","year":"2010","journal-title":"J Ocul Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.mtbio.2025.102537_bib182","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1021\/mp700113r","article-title":"Bioavailability of curcumin: problems and promises","volume":"4","author":"Anand","year":"2007","journal-title":"Mol. Pharm."},{"issue":"2","key":"10.1016\/j.mtbio.2025.102537_bib183","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics9020015","article-title":"Folate decorated nanomicelles loaded with a potent curcumin analogue for targeting retinoblastoma","volume":"9","author":"Alsaab","year":"2017","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.mtbio.2025.102537_bib184","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.ijbiomac.2019.09.085","article-title":"Biodegradable reduction-responsive polymeric micelles for enhanced delivery of melphalan to retinoblastoma cells","volume":"141","author":"Li","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"issue":"3","key":"10.1016\/j.mtbio.2025.102537_bib185","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1080\/10837450.2025.2469321","article-title":"Ocular polymeric nanomicelles for the posterior eye segment in the management of retinoblastoma: formulation, optimization, in vitro and ex vivo evaluations","volume":"30","author":"Ansari","year":"2025","journal-title":"Pharm Dev Technol"},{"key":"10.1016\/j.mtbio.2025.102537_bib186","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125235","article-title":"Functionalization of polymeric nanomicelles and mixed nanomicelles for targeted retinal delivery in the management of retinoblastoma","volume":"671","author":"Ansari","year":"2025","journal-title":"Int J Pharm"},{"key":"10.1016\/j.mtbio.2025.102537_bib187","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.preteyeres.2015.07.005","article-title":"Proliferative vitreoretinopathy: a new concept of disease pathogenesis and practical consequences","volume":"51","author":"Pastor","year":"2016","journal-title":"Prog. Retin. Eye Res."},{"issue":"9","key":"10.1016\/j.mtbio.2025.102537_bib188","first-page":"2693","article-title":"Effect of steroids and nonsteroidal antiinflammatory agents on human ocular fibroblast","volume":"33","author":"Nguyen","year":"1992","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.mtbio.2025.102537_bib189","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.colsurfb.2015.12.053","article-title":"Micellar delivery of dasatinib for the inhibition of pathologic cellular processes of the retinal pigment epithelium","volume":"140","author":"Li","year":"2016","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"1","key":"10.1016\/j.mtbio.2025.102537_bib190","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1038\/s41467-022-30474-6","article-title":"A bio-functional polymer that prevents retinal scarring through modulation of NRF2 signalling pathway","volume":"13","author":"Parikh","year":"2022","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.mtbio.2025.102537_bib191","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22031170","article-title":"Neovascular macular degeneration: a review of etiology, risk factors, and recent advances in research and therapy","volume":"22","author":"Pugazhendhi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.mtbio.2025.102537_bib192","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ophtha.2018.07.028","article-title":"Safety and efficacy of anti-vascular endothelial growth factor therapies for neovascular age-related macular degeneration: a report by the American academy of ophthalmology","volume":"126","author":"Bakri","year":"2019","journal-title":"Ophthalmology"},{"issue":"25","key":"10.1016\/j.mtbio.2025.102537_bib193","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202108360","article-title":"Antiangiogenic nanomicelles for the topical delivery of aflibercept to treat retinal neovascular disease","volume":"34","author":"Zhao","year":"2022","journal-title":"Adv Mater"},{"issue":"11","key":"10.1016\/j.mtbio.2025.102537_bib194","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12111072","article-title":"Self-assembling tacrolimus nanomicelles for retinal drug delivery","volume":"12","author":"Gote","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.mtbio.2025.102537_bib195","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.reth.2024.06.019","article-title":"Novel fabrication of anti-VEGF drug ranibizumab loaded PLGA\/PLA co-polymeric nanomicelles for long-acting intraocular delivery in the treatment of age-related macular degeneration therapy","volume":"26","author":"Xu","year":"2024","journal-title":"Regen Ther"},{"issue":"7","key":"10.1016\/j.mtbio.2025.102537_bib196","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1208\/s12249-019-1404-1","article-title":"Self-assembling topical nanomicellar formulation to improve curcumin absorption across ocular tissues","volume":"20","author":"Alshamrani","year":"2019","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.mtbio.2025.102537_bib197","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/3249064","article-title":"A brief review on the pathological role of decreased blood flow affected in retinitis pigmentosa","volume":"2018","author":"Yang","year":"2018","journal-title":"J Ophthalmol"},{"issue":"4","key":"10.1016\/j.mtbio.2025.102537_bib198","doi-asserted-by":"crossref","first-page":"276","DOI":"10.2174\/138920211795860062","article-title":"Therapeutic challenges to retinitis pigmentosa: from neuroprotection to gene therapy","volume":"12","author":"Sahni","year":"2011","journal-title":"Curr Genomics"},{"issue":"1","key":"10.1016\/j.mtbio.2025.102537_bib199","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2174\/1567201814666170320142136","article-title":"Solubilization and enhancement of Ex vivo vaginal delivery of progesterone using solid dispersions, inclusion complexes and micellar solubilization","volume":"15","author":"Hassan","year":"2018","journal-title":"Curr. Drug Deliv."},{"issue":"8","key":"10.1016\/j.mtbio.2025.102537_bib200","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12080702","article-title":"Micelles of progesterone for topical eye administration: interspecies and intertissues differences in Ex vivo ocular permeability","volume":"12","author":"Alambiaga-Caravaca","year":"2020","journal-title":"Pharmaceutics"},{"issue":"5","key":"10.1016\/j.mtbio.2025.102537_bib201","first-page":"75","article-title":"Diabetic retinopathy: early diagnosis and effective treatment","volume":"107","author":"Kollias","year":"2010","journal-title":"Dtsch Arztebl Int"},{"issue":"9","key":"10.1016\/j.mtbio.2025.102537_bib202","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1016\/j.xphs.2016.03.006","article-title":"\u03b1-Lipoic acid in soluplus(\u00ae) polymeric nanomicelles for ocular treatment of diabetes-associated corneal diseases","volume":"105","author":"Alvarez-Rivera","year":"2016","journal-title":"J Pharm Sci"},{"issue":"11","key":"10.1016\/j.mtbio.2025.102537_bib203","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1016\/j.biomaterials.2011.01.003","article-title":"Anti-Flt1 peptide - hyaluronate conjugate for the treatment of retinal neovascularization and diabetic retinopathy","volume":"32","author":"Oh","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.mtbio.2025.102537_bib204","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jconrel.2014.06.061","article-title":"Role of non-covalent and covalent interactions in cargo loading capacity and stability of polymeric micelles","volume":"193","author":"Ke","year":"2014","journal-title":"J Control Release"},{"issue":"6 Pt 3","key":"10.1016\/j.mtbio.2025.102537_bib205","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.biotechadv.2015.01.003","article-title":"Polymeric micelles in mucosal drug delivery: challenges towards clinical translation","volume":"33","author":"Sosnik","year":"2015","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.mtbio.2025.102537_bib206","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.msec.2017.08.075","article-title":"Overcoming STC2 mediated drug resistance through drug and gene co-delivery by PHB-PDMAEMA cationic polyester in liver cancer cells","volume":"83","author":"Cheng","year":"2018","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"10.1016\/j.mtbio.2025.102537_bib207","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3389\/fchem.2020.00273","article-title":"Enhanced healing and antimicrobial efficacy of Chitosan-g-Polyacrylamide in a rat model of gingival ulcers","volume":"8","author":"Zheng","year":"2020","journal-title":"Front. Chem."},{"key":"10.1016\/j.mtbio.2025.102537_bib208","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2021.129734","article-title":"Engineered bio-adhesive polyhedral oligomeric silsesquioxane hybrid nanoformulation of amphotericin B for prolonged therapy of fungal keratitis","volume":"421","author":"Han","year":"2021","journal-title":"Chem. Eng. J."},{"issue":"3","key":"10.1016\/j.mtbio.2025.102537_bib209","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1080\/17425247.2020.1719995","article-title":"Reduced administration frequency for the treatment of fungal keratitis: a sustained natamycin release from a micellar solution","volume":"17","author":"Guo","year":"2020","journal-title":"Expert Opin Drug Deliv"},{"issue":"3","key":"10.1016\/j.mtbio.2025.102537_bib210","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1124\/jpet.119.256933","article-title":"Ocular drug delivery: present innovations and future challenges","volume":"370","author":"Gote","year":"2019","journal-title":"J Pharmacol Exp Ther"},{"issue":"Suppl 1","key":"10.1016\/j.mtbio.2025.102537_bib211","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1097\/ICL.0000000000000636","article-title":"Efficacy and safety of OTX-101, a novel nanomicellar formulation of cyclosporine A, for the treatment of keratoconjunctivitis sicca: pooled analysis of a phase 2b\/3 and phase 3 study","volume":"46","author":"Sheppard","year":"2020","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.mtbio.2025.102537_bib212","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.2147\/OPTH.S175065","article-title":"A phase II\/III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease","volume":"12","author":"Tauber","year":"2018","journal-title":"Clin. Ophthalmol."},{"issue":"35","key":"10.1016\/j.mtbio.2025.102537_bib213","doi-asserted-by":"crossref","first-page":"5488","DOI":"10.1039\/C8TB01883A","article-title":"Biodegradable polyester unimolecular systems as emerging materials for therapeutic applications","volume":"6","author":"Liu","year":"2018","journal-title":"J. Mater. Chem. B"},{"issue":"6","key":"10.1016\/j.mtbio.2025.102537_bib214","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1089\/jop.2019.0109","article-title":"Micelles: promising ocular drug carriers for anterior and posterior segment diseases","volume":"36","author":"Durgun","year":"2020","journal-title":"J Ocul Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.mtbio.2025.102537_bib215","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0928-0987(03)00178-7","article-title":"The effect of a PEG versus a chitosan coating on the interaction of drug colloidal carriers with the ocular mucosa","volume":"20","author":"De Campos","year":"2003","journal-title":"Eur J Pharm Sci"},{"issue":"18","key":"10.1016\/j.mtbio.2025.102537_bib216","doi-asserted-by":"crossref","first-page":"5240","DOI":"10.1039\/D1NA00596K","article-title":"Flexible polymeric nanosized micelles for ophthalmic drug delivery: research progress in the last three years","volume":"3","author":"Li","year":"2021","journal-title":"Nanoscale Adv."},{"issue":"2","key":"10.1016\/j.mtbio.2025.102537_bib217","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12020146","article-title":"Nanopharmaceutics: part I-Clinical trials legislation and good manufacturing practices (GMP) of nanotherapeutics in the EU","volume":"12","author":"Souto","year":"2020","journal-title":"Pharmaceutics"},{"issue":"13","key":"10.1016\/j.mtbio.2025.102537_bib218","doi-asserted-by":"crossref","first-page":"4490","DOI":"10.1039\/D3BM00505D","article-title":"Nano-based ocular drug delivery systems: an insight into the preclinical\/clinical studies and their potential in the treatment of posterior ocular diseases","volume":"11","author":"Su","year":"2023","journal-title":"Biomater. Sci."},{"issue":"16","key":"10.1016\/j.mtbio.2025.102537_bib219","doi-asserted-by":"crossref","DOI":"10.3390\/nano12162851","article-title":"Hyaluronic acid within self-assembling nanoparticles: endless possibilities for targeted cancer therapy","volume":"12","author":"Curcio","year":"2022","journal-title":"Nanomaterials"},{"issue":"1","key":"10.1016\/j.mtbio.2025.102537_bib220","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1080\/10717544.2018.1428385","article-title":"Comparison of hyaluronic acid-based micelles and polyethylene glycol-based micelles on reversal of multidrug resistance and enhanced anticancer efficacy in vitro and in vivo","volume":"25","author":"Wang","year":"2018","journal-title":"Drug Deliv."},{"key":"10.1016\/j.mtbio.2025.102537_bib221","doi-asserted-by":"crossref","first-page":"6945","DOI":"10.2147\/IJN.S467876","article-title":"Albumin nanoparticle-based drug delivery systems","volume":"19","author":"Qu","year":"2024","journal-title":"Int J Nanomedicine"},{"issue":"4","key":"10.1016\/j.mtbio.2025.102537_bib222","doi-asserted-by":"crossref","DOI":"10.3390\/polym10040462","article-title":"Biomedical applications of chitosan and its derivative nanoparticles","volume":"10","author":"Zhao","year":"2018","journal-title":"Polymers"},{"key":"10.1016\/j.mtbio.2025.102537_bib223","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.ijbiomac.2020.01.162","article-title":"Synthesis of micelles based on chitosan functionalized with gold nanorods as a light sensitive drug delivery vehicle","volume":"149","author":"Pourjavadi","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.mtbio.2025.102537_bib224","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1080\/15685551.2020.1845428","article-title":"Construction of poly(ethylene glycol)-poly(l-lactic acid)-stearic acid reverse aspirin-loaded micelles and optimization of preparation process","volume":"23","author":"Min","year":"2020","journal-title":"Des. Monomers Polym."},{"issue":"6","key":"10.1016\/j.mtbio.2025.102537_bib225","doi-asserted-by":"crossref","DOI":"10.3390\/ma16062298","article-title":"Recent advances on PEO-PCL block and graft copolymers as nanocarriers for drug delivery applications","volume":"16","author":"Chountoulesi","year":"2023","journal-title":"Materials"},{"issue":"5","key":"10.1016\/j.mtbio.2025.102537_bib226","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1049\/iet-nbt.2020.0014","article-title":"Polyacrylamide-punicic acid conjugate-based micelles for flutamide delivery in PC3 cells of prostate cancer: synthesis, characterisation and cytotoxicity studies","volume":"14","author":"Mirsafaei","year":"2020","journal-title":"IET Nanobiotechnol."},{"issue":"2","key":"10.1016\/j.mtbio.2025.102537_bib227","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0021-9797(02)00099-1","article-title":"Cross-linked polyvinylpyrrolidone nanoparticles: a potential carrier for hydrophilic drugs","volume":"258","author":"Bharali","year":"2003","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.mtbio.2025.102537_bib228","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1270699","article-title":"Novel micellar CB2 receptor agonist with anti-inflammatory action for treating corneal alkali burns in a mouse model","volume":"14","author":"Thathapudi","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"21","key":"10.1016\/j.mtbio.2025.102537_bib229","doi-asserted-by":"crossref","DOI":"10.1002\/asia.202200595","article-title":"Production and application of biomaterials based on polyvinyl alcohol (PVA) as wound dressing","volume":"17","author":"Jin","year":"2022","journal-title":"Chem. Asian J."},{"issue":"42","key":"10.1016\/j.mtbio.2025.102537_bib230","doi-asserted-by":"crossref","first-page":"6140","DOI":"10.2174\/1381612821666151027152907","article-title":"Polyethyleneimine-based nanocarriers for gene delivery","volume":"21","author":"Wang","year":"2015","journal-title":"Curr. Pharm. Des."},{"issue":"2","key":"10.1016\/j.mtbio.2025.102537_bib231","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jconrel.2008.09.079","article-title":"Self-assembling micelle-like nanoparticles based on phospholipid-polyethyleneimine conjugates for systemic gene delivery","volume":"133","author":"Ko","year":"2009","journal-title":"J Control Release"},{"issue":"29","key":"10.1016\/j.mtbio.2025.102537_bib232","doi-asserted-by":"crossref","first-page":"9240","DOI":"10.1021\/la4017678","article-title":"Nanofibrillar micelles and entrapped vesicles from biodegradable block copolymer\/polyelectrolyte complexes in aqueous media","volume":"29","author":"Salim","year":"2013","journal-title":"Langmuir"},{"issue":"9","key":"10.1016\/j.mtbio.2025.102537_bib233","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/mabi.200400043","article-title":"An overview of polylactides as packaging materials","volume":"4","author":"Auras","year":"2004","journal-title":"Macromol. Biosci."},{"issue":"21","key":"10.1016\/j.mtbio.2025.102537_bib234","doi-asserted-by":"crossref","DOI":"10.3390\/ma14216650","article-title":"Modulation of the PLLA morphology through racemic nucleation to reach functional properties required by 3D printed durable applications","volume":"14","author":"Dimonie","year":"2021","journal-title":"Materials"},{"issue":"2","key":"10.1016\/j.mtbio.2025.102537_bib235","doi-asserted-by":"crossref","DOI":"10.3390\/polym12020288","article-title":"Controllable drug release behavior of polylactic acid (PLA) surgical suture coating with ciprofloxacin (CPFX)-polycaprolactone (PCL)\/polyglycolide (PGA)","volume":"12","author":"Liu","year":"2020","journal-title":"Polymers"},{"issue":"1\u20132","key":"10.1016\/j.mtbio.2025.102537_bib236","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ijpharm.2003.08.020","article-title":"The effects of molecular weight and porosity on the degradation and drug release from polyglycolide","volume":"282","author":"Braunecker","year":"2004","journal-title":"Int J Pharm"},{"issue":"21","key":"10.1016\/j.mtbio.2025.102537_bib237","doi-asserted-by":"crossref","DOI":"10.3390\/polym15214304","article-title":"Remote outcomes with Poly-\u03b5-Caprolactone aortic grafts in rats","volume":"15","author":"Dokuchaeva","year":"2023","journal-title":"Polymers"},{"issue":"7\u20139","key":"10.1016\/j.mtbio.2025.102537_bib238","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1080\/09205063.2017.1394711","article-title":"PCL and PCL-Based materials in biomedical applications","volume":"29","author":"Malikmammadov","year":"2018","journal-title":"J. Biomater. Sci. Polym. Ed."},{"issue":"6","key":"10.1016\/j.mtbio.2025.102537_bib239","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22062792","article-title":"Biodegradable nanoparticles-loaded PLGA microcapsule for the enhanced encapsulation efficiency and controlled release of hydrophilic drug","volume":"22","author":"Ryu","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.mtbio.2025.102537_bib240","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1021\/acsami.1c22009","article-title":"Direct cellular delivery of exogenous genetic material and protein via colloidal nano-assemblies with biopolymer","volume":"14","author":"Sarkar","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"1","key":"10.1016\/j.mtbio.2025.102537_bib241","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ijpharm.2017.08.082","article-title":"Formulation and characterization of biocompatible and stable I.V. itraconazole nanosuspensions stabilized by a new stabilizer polyethylene glycol-poly(\u03b2-Benzyl-l-aspartate) (PEG-PBLA)","volume":"531","author":"Zong","year":"2017","journal-title":"Int J Pharm"},{"key":"10.1016\/j.mtbio.2025.102537_bib242","doi-asserted-by":"crossref","first-page":"823","DOI":"10.3389\/fonc.2019.00823","article-title":"Redox-responsive disulfide bond-bridged mPEG-PBLA prodrug micelles for enhanced paclitaxel biosafety and antitumor efficacy","volume":"9","author":"Chang","year":"2019","journal-title":"Front. Oncol."},{"issue":"30","key":"10.1016\/j.mtbio.2025.102537_bib243","doi-asserted-by":"crossref","first-page":"25006","DOI":"10.1021\/acsami.8b04259","article-title":"Preparation of PGA-PAE-Micelles for enhanced antitumor efficacy of cisplatin","volume":"10","author":"Chen","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"1","key":"10.1016\/j.mtbio.2025.102537_bib244","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-78244-2","article-title":"Self-assembled latanoprost loaded soluplus nanomicelles as an ophthalmic drug delivery system for the management of glaucoma","volume":"14","author":"Gohar","year":"2024","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.mtbio.2025.102537_bib245","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1023\/B:PHAM.0000033005.25698.9c","article-title":"Preparation and drug loading of poly(ethylene glycol)-block-poly(epsilon-caprolactone) micelles through the evaporation of a cosolvent azeotrope","volume":"21","author":"Jette","year":"2004","journal-title":"Pharm. Res."},{"issue":"49","key":"10.1016\/j.mtbio.2025.102537_bib246","doi-asserted-by":"crossref","first-page":"30532","DOI":"10.1039\/D1RA04242D","article-title":"PEGylated ethyl cellulose micelles as a nanocarrier for drug delivery","volume":"11","author":"Singam","year":"2021","journal-title":"RSC Adv."},{"issue":"4","key":"10.1016\/j.mtbio.2025.102537_bib247","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1021\/bm4018879","article-title":"Dithiol-PEG-PDLLA micelles: preparation and evaluation as potential topical ocular delivery vehicle","volume":"15","author":"Yang","year":"2014","journal-title":"Biomacromolecules"},{"issue":"5","key":"10.1016\/j.mtbio.2025.102537_bib248","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1208\/s12249-014-0100-4","article-title":"Novel dexamethasone-loaded nanomicelles for the intermediate and posterior segment uveitis","volume":"15","author":"Vaishya","year":"2014","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"10.1016\/j.mtbio.2025.102537_bib249","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ijpharm.2016.06.013","article-title":"Lenghty reverse poly(butylene oxide)-poly(ethylene oxide)-poly(butylene oxide) polymeric micelles and gels for sustained release of antifungal drugs","volume":"510","author":"Figueroa-Ochoa","year":"2016","journal-title":"Int J Pharm"},{"key":"10.1016\/j.mtbio.2025.102537_bib250","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jconrel.2017.01.012","article-title":"Polymeric micelles for ocular drug delivery: from structural frameworks to recent preclinical studies","volume":"248","author":"Mandal","year":"2017","journal-title":"J Control Release"},{"key":"10.1016\/j.mtbio.2025.102537_bib251","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124258","article-title":"Anti-angiogenic biomolecules in neovascular age-related macular degeneration; therapeutics and drug delivery systems","volume":"659","author":"Kazemi","year":"2024","journal-title":"Int J Pharm"},{"issue":"6","key":"10.1016\/j.mtbio.2025.102537_bib252","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2174\/156652311798192879","article-title":"Progress and prospects of polyplex nanomicelles for plasmid DNA delivery","volume":"11","author":"Itaka","year":"2011","journal-title":"Curr. Gene Ther."},{"issue":"5","key":"10.1016\/j.mtbio.2025.102537_bib253","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1208\/s12249-025-03129-0","article-title":"Development and evaluation of cyclosporine a mixed micelle eye drops for enhanced ocular drug delivery","volume":"26","author":"Hu","year":"2025","journal-title":"AAPS PharmSciTech"},{"issue":"4","key":"10.1016\/j.mtbio.2025.102537_bib254","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics10040208","article-title":"Development and evaluation of a water soluble fluorometholone eye drop formulation employing polymeric micelle","volume":"10","author":"Noh","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.mtbio.2025.102537_bib255","article-title":"Mucoadhesive micelles for ophthalmic drug delivery","author":"Goostrey","year":"2025","journal-title":"J. Biomater. Appl."},{"issue":"11","key":"10.1016\/j.mtbio.2025.102537_bib256","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1080\/03639045.2017.1349787","article-title":"New nanomicelle curcumin formulation for ocular delivery: improved stability, solubility, and ocular anti-inflammatory treatment","volume":"43","author":"Li","year":"2017","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"10","key":"10.1016\/j.mtbio.2025.102537_bib257","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16101325","article-title":"Advancements in ocular therapy: a review of emerging drug delivery approaches and pharmaceutical technologies","volume":"16","author":"Giri","year":"2024","journal-title":"Pharmaceutics"},{"issue":"5","key":"10.1016\/j.mtbio.2025.102537_bib258","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1080\/17425247.2016.1227783","article-title":"Recent perspectives on the delivery of biologics to back of the eye","volume":"14","author":"Joseph","year":"2017","journal-title":"Expert Opin Drug Deliv"},{"issue":"6","key":"10.1016\/j.mtbio.2025.102537_bib259","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13060855","article-title":"Preliminary investigation on simvastatin-loaded polymeric micelles in view of the treatment of the back of the eye","volume":"13","author":"Pescina","year":"2021","journal-title":"Pharmaceutics"},{"issue":"5","key":"10.1016\/j.mtbio.2025.102537_bib260","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/jbm.b.32871","article-title":"Novel pluronic-chitosan micelle as an ocular delivery system","volume":"101","author":"Lin","year":"2013","journal-title":"J. Biomed. Mater. Res. B Appl. Biomater."},{"issue":"6","key":"10.1016\/j.mtbio.2025.102537_bib261","doi-asserted-by":"crossref","first-page":"675","DOI":"10.4103\/0250-474X.84575","article-title":"Nano-vectors for the ocular delivery of nucleic acid-based therapeutics","volume":"72","author":"Khar","year":"2010","journal-title":"Indian J Pharm Sci"},{"issue":"1","key":"10.1016\/j.mtbio.2025.102537_bib262","doi-asserted-by":"crossref","DOI":"10.3390\/nano11010070","article-title":"Recent advances in nanomicelles delivery systems","volume":"11","author":"Tawfik","year":"2020","journal-title":"Nanomaterials"},{"issue":"1","key":"10.1016\/j.mtbio.2025.102537_bib263","article-title":"Nanomicelle-assisted targeted ocular delivery with enhanced antiinflammatory efficacy in vivo","volume":"5","author":"Weng","year":"2018","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"5","key":"10.1016\/j.mtbio.2025.102537_bib264","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/wnan.1272","article-title":"Controlled ocular drug delivery with nanomicelles","volume":"6","author":"Vaishya","year":"2014","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"issue":"13","key":"10.1016\/j.mtbio.2025.102537_bib265","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1016\/j.biomaterials.2009.01.006","article-title":"Dual-drug delivery system based on hydrogel\/micelle composites","volume":"30","author":"Wei","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.mtbio.2025.102537_bib266","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2023.1246974","article-title":"Recent development of polymer nanomicelles in the treatment of eye diseases","volume":"11","author":"Cai","year":"2023","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"46","key":"10.1016\/j.mtbio.2025.102537_bib267","doi-asserted-by":"crossref","first-page":"27835","DOI":"10.1039\/D0RA04971A","article-title":"Nanocarriers for ocular drug delivery: current status and translational opportunity","volume":"10","author":"Gorantla","year":"2020","journal-title":"RSC Adv."},{"issue":"1","key":"10.1016\/j.mtbio.2025.102537_bib268","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25010081","article-title":"A novel gel-forming solution based on PEG-DSPE\/Solutol HS 15 mixed micelles and gellan gum for ophthalmic delivery of curcumin","volume":"25","author":"Sai","year":"2019","journal-title":"Molecules"},{"issue":"33","key":"10.1016\/j.mtbio.2025.102537_bib269","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6528\/ad4ee5","article-title":"ROS-responsive celastrol-nanomedicine alleviates inflammation for dry eye disease","volume":"35","author":"Cui","year":"2024","journal-title":"Nanotechnology"},{"issue":"4","key":"10.1016\/j.mtbio.2025.102537_bib270","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1167\/iovs.11-8829","article-title":"A novel cyclosporin a aqueous formulation for dry eye treatment: in vitro and in vivo evaluation","volume":"53","author":"Di Tommaso","year":"2012","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"4","key":"10.1016\/j.mtbio.2025.102537_bib271","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1021\/acs.biomac.6b00054","article-title":"Phenylboronic-acid-based polymeric micelles for mucoadhesive anterior segment ocular drug delivery","volume":"17","author":"Prosperi-Porta","year":"2016","journal-title":"Biomacromolecules"},{"issue":"1","key":"10.1016\/j.mtbio.2025.102537_bib272","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1021\/acsami.3c12389","article-title":"Thermosensitive triblock copolymer for slow-release lubricants under ocular conditions","volume":"16","author":"Wang","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"6","key":"10.1016\/j.mtbio.2025.102537_bib273","doi-asserted-by":"crossref","first-page":"753","DOI":"10.2174\/1567201811666140605151923","article-title":"Poly(ethylene glycol)-block-poly(\u03b5-caprolactone) nanomicelles for the solubilization and enhancement of antifungal activity of sertaconazole","volume":"11","author":"Soliman","year":"2014","journal-title":"Curr. Drug Deliv."},{"issue":"6","key":"10.1016\/j.mtbio.2025.102537_bib274","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1177\/08853282221141962","article-title":"Biocompatible phospholipid-based mixed micelles for posaconazole ocular delivery: development, characterization, and in - vitro antifungal activity","volume":"37","author":"Osouli","year":"2023","journal-title":"J. Biomater. Appl."},{"key":"10.1016\/j.mtbio.2025.102537_bib275","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ejps.2019.03.023","article-title":"Tacrolimus-loaded methoxy poly(ethylene glycol)-block-poly(d,l)-lactic-co-glycolic acid micelles self-assembled in aqueous solution for treating cornea immune rejection after allogenic penetrating keratoplasty in rats","volume":"133","author":"Liu","year":"2019","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.mtbio.2025.102537_bib276","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2019.03.022","article-title":"A novel FK506 loaded nanomicelles consisting of amino-terminated poly(ethylene glycol)-block-poly(d,l)-lactic acid and hydroxypropyl methylcellulose for ocular drug delivery","volume":"562","author":"Liu","year":"2019","journal-title":"Int J Pharm"},{"key":"10.1016\/j.mtbio.2025.102537_bib277","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.ijpharm.2019.06.011","article-title":"Exploring optimized methoxy poly(ethylene glycol)-block-poly(\u03b5-caprolactone) crystalline cored micelles in anti-glaucoma pharmacotherapy","volume":"566","author":"Elmowafy","year":"2019","journal-title":"Int J Pharm"},{"key":"10.1016\/j.mtbio.2025.102537_bib278","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ejpb.2023.02.011","article-title":"A triple crosslinked micelle-hydrogel lacrimal implant for localized and prolonged therapy of glaucoma","volume":"185","author":"Zhao","year":"2023","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"16","key":"10.1016\/j.mtbio.2025.102537_bib279","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23169382","article-title":"Drug-loaded polymeric micelles based on smart biocompatible graft copolymers with potential applications for the treatment of glaucoma","volume":"23","author":"Ozturk","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mtbio.2025.102537_bib280","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ijpharm.2019.01.051","article-title":"Micelle-solubilized axitinib for ocular administration in anti-neovascularization","volume":"560","author":"Shi","year":"2019","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.mtbio.2025.102537_bib281","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1080\/10717544.2018.1474972","article-title":"Hyaluronic acid modified MPEG-b-PAE block copolymer aqueous micelles for efficient ophthalmic drug delivery of hydrophobic genistein","volume":"25","author":"Li","year":"2018","journal-title":"Drug Deliv."},{"issue":"18","key":"10.1016\/j.mtbio.2025.102537_bib282","doi-asserted-by":"crossref","DOI":"10.3390\/polym13183038","article-title":"Development and evaluation of polyvinylpyrrolidone K90 and poloxamer 407 self-assembled nanomicelles: enhanced topical ocular delivery of artemisinin","volume":"13","author":"Ponnusamy","year":"2021","journal-title":"Polymers"},{"issue":"2","key":"10.1016\/j.mtbio.2025.102537_bib283","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics10020057","article-title":"Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems","volume":"10","author":"Danaei","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.mtbio.2025.102537_bib284","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jconrel.2016.06.017","article-title":"DLS and zeta potential - what they are and what they are not?","volume":"235","author":"Bhattacharjee","year":"2016","journal-title":"J Control Release"},{"issue":"26","key":"10.1016\/j.mtbio.2025.102537_bib285","doi-asserted-by":"crossref","first-page":"27888","DOI":"10.1021\/acsomega.3c07033","article-title":"Magnetically controlled intraocular delivery of dexamethasone using silica-coated magnetic nanoparticles","volume":"9","author":"Noh","year":"2024","journal-title":"ACS Omega"},{"issue":"8","key":"10.1016\/j.mtbio.2025.102537_bib286","first-page":"526","article-title":"Self-assembled nanomicelles to enhance solubility and anticancer activity of etoposide, assay drug","volume":"19","author":"Alsalhi","year":"2021","journal-title":"Dev Technol"},{"issue":"1","key":"10.1016\/j.mtbio.2025.102537_bib287","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14010050","article-title":"Thermosensitive Poly(DHSe\/PEG\/PPG Urethane)-Based hydrogel extended remdesivir application in ophthalmic medication","volume":"14","author":"Xu","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.mtbio.2025.102537_bib288","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124110","article-title":"Formulation and in Vitro-Ex vivo evaluation of cannabidiol and cannabidiol-valine-hemisuccinate loaded lipid-based nanoformulations for ocular applications","volume":"657","author":"Adel Ali Youssef","year":"2024","journal-title":"Int J Pharm"},{"issue":"4","key":"10.1016\/j.mtbio.2025.102537_bib289","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2217\/nnm.10.29","article-title":"Ambiguities in applying traditional limulus amebocyte lysate tests to quantify endotoxin in nanoparticle formulations","volume":"5","author":"Dobrovolskaia","year":"2010","journal-title":"Nanomedicine (Lond)"},{"issue":"8","key":"10.1016\/j.mtbio.2025.102537_bib290","doi-asserted-by":"crossref","first-page":"10611","DOI":"10.1007\/s00210-025-03919-0","article-title":"Micelle nanogel-based drug delivery system for lutein in ocular administration","volume":"398","author":"Shetty","year":"2025","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"issue":"4","key":"10.1016\/j.mtbio.2025.102537_bib291","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3109\/03639045.2015.1082582","article-title":"A novel eye drop of alpha tocopherol to prevent ocular oxidant damage: improve the stability and ocular efficacy","volume":"42","author":"Xin","year":"2016","journal-title":"Drug Dev. Ind. Pharm."}],"container-title":["Materials Today Bio"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006425011081?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006425011081?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T07:15:23Z","timestamp":1773818123000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590006425011081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":290,"alternative-id":["S2590006425011081"],"URL":"https:\/\/doi.org\/10.1016\/j.mtbio.2025.102537","relation":{},"ISSN":["2590-0064"],"issn-type":[{"value":"2590-0064","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From design to Deployment: The innovative role of nanomicelles in targeted ophthalmic therapeutics","name":"articletitle","label":"Article Title"},{"value":"Materials Today Bio","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mtbio.2025.102537","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102537"}}